Standard Temodal (Temozolomide) Regimen Versus Standard Regimen Plus Early Postsurgery Temodal for Newly Diagnosed Glioblastoma Multiforme (Study P05572)
Clinical trial NCT00686725 · COMPLETED
Trial details
- NCT number
- NCT00686725
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2008-06-24
- Primary completion
- 2011-09-28
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.